Endocrine Abstracts

Introduction: Glargine is a recombinant human insulin analogue, used in the treatment of diabetes mellitus. Although widely used, information regarding the altered time-effect profile of glargine taken in overdose is scarce. We describe a case which highlights this phenomenon.Case report: An 82-year-old female was found by her neighbour, 18 h after attempting suicide by injecting herself with 600 units of glargine at multiple sites. Her capillary blood g...

To determine our adherence to the Consensus Development Conference on the Management of Asymptomatic Primary Hyperparathyroidism (2002) guidelines, we audited the management of all patients referred to our endocrine unit with the diagnosis of primary hyperparathyroidism during January 2003 to December 2004.Overall 36 patients were referred. 32 were females and the mean age was 64 years.19 patients were Caucasians, 8 were Asians and 9 patients were of Afr...

Endocrinopathies are amongst the most common complications of thallasaemia, which is a hereditary disorder of haemoglobin synthesis and excessive iron deposition is thought to be the main reason.Our hospital serves a multiethnic population and consequently we see a substantial number of patients with thallasaemia who are screened for endocrine complications. Those found to have endocrine problems are reviewed in our joint thallasaemia-endocrine clinic. B...